Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Allos Therapeutics, Inc. (MM) (ALTH)

Allos Therapeutics, Inc. (MM)
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ALTH
DateTimeSourceHeadlineSymbolCompany
05/12/200713:00PR Newswire (US)Allos Therapeutics to Present at the 2007 RBC Capital Markets Healthcare ConferenceNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
30/11/200722:37Edgar (US Regulatory)Allos Therapeutics Inc - Statement of Changes in Beneficial Ownership (4)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
29/11/200713:00PR Newswire (US)Allos Therapeutics to Present at the 2007 BMO Capital Markets Focus on Healthcare ConferenceNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
20/11/200713:00PR Newswire (US)Allos Therapeutics to Present at the 2007 Lazard Capital Markets Healthcare Investor ConferenceNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
12/11/200721:00PR Newswire (US)Allos Therapeutics Initiates Study of RH1 in Patients with Advanced Solid Tumors or non-Hodgkin's LymphomaNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
07/11/200721:00PR Newswire (US)Allos Therapeutics to Present at the 2007 JMP Securities Healthcare Focus ConferenceNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
05/11/200719:02Edgar (US Regulatory)Allos Therapeutics Inc - Quarterly Report (10-Q)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
05/11/200713:03Edgar (US Regulatory)Allos Therapeutics Inc - Current report filing (8-K)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
05/11/200712:30PR Newswire (US)Allos Therapeutics Reports Third Quarter 2007 Financial ResultsNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
31/10/200712:00PR Newswire (US)Allos Therapeutics to Present at the 2007 Acumen BioFin Rodman & Renshaw ConferenceNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
25/10/200722:06Edgar (US Regulatory)Allos Therapeutics Inc - Current report filing (8-K)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
25/10/200721:01PR Newswire (US)Three PDX (Pralatrexate) Studies Presented at the 2007 AACR-NCI-EORTC ConferenceNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
17/10/200721:58Edgar (US Regulatory)Allos Therapeutics Inc - Statement of Changes in Beneficial Ownership (4)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
16/10/200712:55PR Newswire (US)Allos Therapeutics to Report 2007 Third Quarter Financial Results on November 5, 2007NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
09/10/200721:51Edgar (US Regulatory)Allos Therapeutics Inc - Statement of Changes in Beneficial Ownership (4)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
26/09/200715:43Edgar (US Regulatory)Allos Therapeutics Inc (Other) (SC 13G)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
24/09/200720:35Edgar (US Regulatory)Allos Therapeutics Inc (Other) (8-K)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
24/09/200712:30PR Newswire (US)Interim Response and Safety Analyses Support Continuation of Allos Therapeutics' Pivotal Phase 2 PROPEL Trial of PDX in PatientsNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
13/09/200713:00PR Newswire (US)Allos Therapeutics to Present at the 2007 UBS Global Life Sciences ConferenceNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
04/09/200713:00PR Newswire (US)Allos Therapeutics to Present at the Bear Stearns 20th Annual Healthcare ConferenceNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
15/08/200713:00PR Newswire (US)Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell LymphomaNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
07/08/200714:00PR Newswire (US)Allos Therapeutics Reports Second Quarter 2007 Financial ResultsNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
18/07/200713:00PR Newswire (US)Allos Therapeutics to Report 2007 Second Quarter Financial Results on August 7, 2007NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
25/06/200714:30PR Newswire (US)Allos Therapeutics Selected to Join Russel 3000 IndexNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
19/06/200711:30PR Newswire (US)Allos Therapeutics Reports Results for Phase 3 Enrich Study of Efaproxyn in Women With Brain Metastases Originating From BreastNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
31/05/200722:01PR Newswire (US)Allos Therapeutics Initiates Phase I/II Study of PDX and Gemcitabine in Patients With Non-Hodgkin's Lymphoma or Hodgkin's DiseasNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
23/05/200722:55PR Newswire (US)Allos Therapeutics Files Shelf Registration StatementNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
08/05/200713:30PR Newswire (US)Allos Therapeutics Reports First Quarter 2007 Financial ResultsNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
01/05/200718:21PR Newswire (US)Allos Therapeutics to Announce 2007 First Quarter Results on Tuesday, May 8NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
26/04/200713:00PR Newswire (US)Allos Therapeutics Appoints Dr. Jeffrey R. Latts to Its Board of DirectorsNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
 Showing the most relevant articles for your search:NASDAQ:ALTH

Your Recent History

Delayed Upgrade Clock